NextHealth vs ACASA Senior Care

ACASA Senior Care is the clear near-term target. The budget dimension seals it—$6.9M AUV versus $4M at NextHealth means each ACASA unit can justify more software spend without the operator feeling it. Seven franchised units (against zero at NextHealth) give you a real, albeit small, TAM you can sell into today. And that 40% unit growth signals momentum; you're not pitching a static book, you're catching a brand that’s actively adding new doors, each needing a tech stack from scratch. The terrain is also friendlier: an approved-supplier procurement model means you sell the franchisee directly—no gatekeeper blocking your deal at the parent level.

NextHealth’s numbers tell a cautionary tale. Zero franchised units means you’re betting entirely on corporate-owned locations—a slog of centralized procurement cycles with no franchisee multiplier. The franchisor-controlled procurement model amplifies the terrain risk: you have to win one monolithic buyer, and if you lose, you lose everything. The single meaningful tradeoff is that if you do crack NextHealth’s corporate account, you might land a high-commitment, full-portfolio deal with minimal ongoing sales cost—but that’s a long-shot play with a $2.2M max investment cap that screens for well-capitalized, process-heavy operators who won’t move fast.

For a software vendor prioritizing pipeline velocity and repeatable sales motions, ACASA’s franchisee-direct motion wins on budget, TAM, and timing. You can close a handful of small, high-AUV operators now, build references, and ride their unit growth. NextHealth is a future opportunity to monitor once they start franchising—if they ever do.

Verdict: Sell ACASA now for fast deals and franchisee wallet share; watch NextHealth as a high-risk, single-buyer corporate bet.